() 2018-2019 Prior Authorization Form - IEHP Preview on Page 1

() 2018-2019 Prior Authorization Form - IEHP-2026

The document is a Prior Authorization Form for Synagis (palivizumab) for the 2018-2019 season, intended for patients at risk of severe respiratory syncytial virus (RSV) infection. It includes sections for patient and physician information, medical necessity criteria, additional risk factors, and prescription details. The form requires specific patient data such as gestational age, current age, and weight, along with physician signatures to authorize the administration of the medication.

Here's how it works

01. Edit your form online
Type text, add images, blackout confidential details, add comments, highlights and more.
02. Sign it in a few clicks
Draw your signature, type it, upload its image, or use your mobile device as a signature pad.
03. Share your form with others
Send it via email, link, or fax. You can also download it, export it or print it out.

Definition & Meaning

The 2 Prior Authorization Form - IEHP facilitates the pre-approval process for patients requiring Synagis (palivizumab) to prevent severe respiratory syncytial virus (RSV) infections. This document is essential for capturing detailed medical and patient data to justify the necessity for treatment, ensuring that insurance coverage aligns with medical needs.

How to Use the 2 Prior Authorization Form - IEHP

To effectively utilize this form, applicants need to fill in specific sections with accurate information. Upon completion, it should be submitted to the Inland Empire Health Plan (IEHP) for review. The form requires details such as patient demographics, physician information, and a medical rationale for Synagis, ensuring the patient's eligibility is adequately assessed.

Sections to Fill

Patient Information: Includes name, date of birth, and insurance ID.
Physician Details: Requires the doctor's name, contact information, and medical ID number.
Medical Necessity: Justification for Synagis use, including diagnosis and risk factors.

Key Elements of the 2 Prior Authorization Form - IEHP

The form comprises several critical sections essential for processing authorization:

Patient and Physician Data: Accurate details are mandatory to match patient records with physician authorizations.
Medical Necessity Criteria: Specific conditions or risk factors must be outlined to validate the need for Synagis.
Prescription Details: Includes dosage and administration schedule as advised by the healthcare provider.

Additional Components

Gestational Age and Weight: Specific to infant patients, these details are required for evaluating eligibility based on development factors.
Signature Fields: Both physician and parent or guardian must provide signatures to affirm consent and verification of information.

Steps to Complete the 2 Prior Authorization Form - IEHP

Gather Required Information: Collect all necessary patient and medical details prior to filling out the form to ensure accuracy.
Complete Each Section: Follow the instructions carefully in each section, providing thorough data where requested.
Double-check Entries: Verify all entered information to avoid processing delays due to errors or omissions.
Obtain Signatures: Secure the necessary signatures from both the healthcare provider and the patient’s legal guardian.
Submit the Form: Send the completed form to the IEHP, ensuring it's within any specified submission deadline to avoid delays in processing.

Legal Use of the 2 Prior Authorization Form - IEHP

The form aligns with legal requirements set by healthcare providers and insurance regulators to ensure that pre-authorization adheres to both local and federal laws. It ensures that medications like Synagis are administered judiciously, supporting patient health while managing medical costs effectively.

Compliance Factors

HIPAA Regulations: Patient data collected must comply with HIPAA standards to protect privacy.
Insurance Protocols: Corresponds with insurance guidelines to determine coverage eligibility.

Eligibility Criteria

Eligibility for Synagis requires that certain medical conditions and criteria be met. These include infants with specific respiratory or cardiovascular conditions that increase their risk of RSV infections. Accurate documentation of these conditions is crucial for approval.

Specific Conditions

Premature Births: Infants born prematurely may have heightened eligibility due to underdeveloped lungs.
Chronic Lung Disease: Past medical history of lung issues could be an influencing factor.

Submission Methods for the 2 Prior Authorization Form - IEHP

Participants can choose various methods for submitting the form, ensuring accessibility and convenience in different healthcare and personal situations.

Available Options

Online Submission: Preferred for speed and ease, the form can be uploaded on the IEHP's digital platform.
Mail Submission: Traditional mailing is an option, though it may result in longer processing times.
In-Person Submission: Direct submission at local IEHP offices may be suitable for those seeking immediate confirmation of receipt.

Versions or Alternatives to the 2 Prior Authorization Form - IEHP

While this specific form pertains to the 2 cycle, updated versions are typically released annually or bi-annually to reflect current medical guidelines and regulatory requirements. Stakeholders should verify they are using the most current version to ensure compliance and efficient processing.

Importance of Updated Forms

Using the latest version ensures adherence to the most recent insurance policies and medical standards, which is crucial for the approval of treatments like Synagis.

be ready to get more

Complete this form in 5 minutes or less

Get form

Who is responsible for obtaining preauthorization?

Studies show the average cost for prior authorization approval on primary care practices ranged from $2,161 to $3,430 annually per full-time physician. In addition to the impact on physicians, prior authorization requirements have been found to harm patient care.

How do I submit a prior authorization to Medi-Cal?

Pharmacy providers and prescribers can submit a PA request via fax number 1-800-869-4325 by utilizing the preferred Medi-Cal Rx Prior Authorization Request form (DHCS 6560) or any of the following approved forms: 50-1, 50-2, 61-211.

How to obtain prior authorization?

How To Get Prior Authorization: Step-by-Step Guide Step 1: Check client eligibility. Step 2: Determine if a code or service requires Prior Authorization. Step 3: Find and complete forms. Step 4: Submit a PA request. Step 5: Check the status of an authorization.

How to get a prior authorization form?

To receive coverage for a medication requiring prior authorization, you can: Ask your healthcare provider to submit the request. Your healthcare provider can submit the request online, by fax or phone by accessing our providers prior authorization information. Submit your own prior authorization request.

Can I request my own prior authorization?

You can submit a request on your own. Find the appropriate prescription drug or medical procedure authorization form for your situation.